The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region

被引:157
作者
Nardone, A.
de Ory, F.
Carton, M.
Cohen, D.
van Damme, P.
Davidkin, I.
Rota, M. C.
de Melker, H.
Mossong, J.
Slacikova, M.
Tischer, A.
Andrews, N.
Berbers, G.
Gabutti, G.
Gay, N.
Jones, L.
Jokinen, S.
Kafatos, G.
Martinez de Aragon, M. V.
Schneider, F.
Smetana, Z.
Vargova, B.
Vranckx, R.
Miller, E.
机构
[1] Hlth Protect Agcy, Ctr Infect, London, England
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
[3] Natl Dis Surveillance Ctr, Dublin, Ireland
[4] Tel Aviv Univ, Tel Hashomer & Sackler Fac Med, Israel Ctr Dis Control, IL-69978 Tel Aviv, Israel
[5] Univ Antwerp, B-2020 Antwerp, Belgium
[6] Natl Publ Hlth Inst, KTL, Helsinki, Finland
[7] Ist Super Sanita, I-00161 Rome, Italy
[8] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands
[9] Lab Natl Sante, Luxembourg, Luxembourg
[10] Publ Hlth Author Slovak Republ, Bratislava, Slovakia
[11] Robert Koch Inst, D-1000 Berlin, Germany
[12] Univ Ferrara, I-44100 Ferrara, Italy
[13] Natl Virus Reference Lab, Dublin, Ireland
[14] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain
[15] Cent Virol Lab, Tel Hashomer, Israel
[16] Sci Inst Publ Hlth, Brussels, Belgium
关键词
varicella zoster virus; seroepidemiology; vaccination;
D O I
10.1016/j.vaccine.2007.07.036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The European sero-epidemiology network (ESEN2) aims to standardise serological surveillance of varicella zoster virus (VZV) in I I participant countries. In each country, serum banks were collected between 1996 and 2003 and tested for VZV antibodies. Assay results were standardised so that international comparisons could be made. Age-specific forces of infection were calculated for three age groups (<5, 5-9 and >= 10 years of age) and used to estimate the base reproduction number (R-0) and the herd immunity threshold (H). Most VZV infection occurred in childhood, but there was a wide variation in transmissibility, with R-0 ranging from 16.9 in the Netherlands to 3.3 in Italy. Herd immunity thresholds varied from 70% in Italy to 94% in the Netherlands. There are substantial differences in VZV sero-epidemiology within the European region, which will need to be taken into account in designing national policies regarding VZV vaccination. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7866 / 7872
页数:7
相关论文
共 43 条
  • [1] Age-specific seroprevalence to varicella-zoster virus:: study in Swiss children and analysis of European data
    Aebi, C
    Fischer, K
    Gorgievski, M
    Matter, L
    Mühlemann, K
    [J]. VACCINE, 2001, 19 (23-24) : 3097 - 3103
  • [2] ANDERSON R M, 1991
  • [3] ROLE OF EPIDEMIOLOGY IN VACCINE POLICY
    BEGG, N
    MILLER, E
    [J]. VACCINE, 1990, 8 (03) : 180 - 189
  • [4] Varicella in non-immune persons:: incidence, hospitalization and mortality rates
    Boëlle, PY
    Hanslik, T
    [J]. EPIDEMIOLOGY AND INFECTION, 2002, 129 (03) : 599 - 606
  • [5] Modelling the impact of immunization on the epidemiology of varicella zoster virus
    Brisson, M
    Edmunds, WJ
    Gay, NJ
    Law, B
    De Serres, G
    [J]. EPIDEMIOLOGY AND INFECTION, 2000, 125 (03) : 651 - 669
  • [6] Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
    Brisson, M
    Edmunds, WJ
    Law, B
    Gay, NJ
    Walld, R
    Brownell, M
    Roos, L
    De Serres, G
    [J]. EPIDEMIOLOGY AND INFECTION, 2001, 127 (02) : 305 - 314
  • [7] Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina
    Clements, DA
    Zaref, JI
    Bland, CL
    Walter, EB
    Coplan, PM
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2001, 155 (04): : 455 - 461
  • [8] Seroepidemiology of Varicella zoster in Israel prior to large-scale use of Varicella vaccines
    Cohen, D. I.
    Davidovici, B. B.
    Smetana, Z.
    Balicer, R. D.
    Klement, E.
    Mendelson, E.
    Green, M. S.
    [J]. INFECTION, 2006, 34 (04) : 208 - 213
  • [9] Non-participation in a population-based seroprevalence study of vaccine-preventable diseases
    De Melker, HE
    Nagelkerde, NJD
    Conyn-Van Spaendonck, MAE
    [J]. EPIDEMIOLOGY AND INFECTION, 2000, 124 (02) : 255 - 262
  • [10] The epidemiology of varicella and herpes zoster in The Netherlands:: Implications for varicella zoster virus vaccination
    de Melker, Hester
    Berbers, Guy
    Hahne, Susan
    Rumke, Hans
    van den Hof, Susan
    de Wit, Ardine
    Boot, Hein
    [J]. VACCINE, 2006, 24 (18) : 3946 - 3952